Latest Corporate News

Pharmascience Inc. contributes to the Montreal Heart Institute's COLchicine Cardiovascular Outcome Trial (COLCOT)

A landmark study to benefit cardiovascular patients and the healthcare system.


Pharmascience Inc. launches pms-FINGOLIMOD for the treatment of relapsing-remitting multiple sclerosis (MS) in adults


Prospan by Helixia and Lax-A-Day, Over-The-Counter drugs manufactured by Pharmascience distinguished in their categories